CoreAge Rx vs Rylo Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Rylo Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Rylo Health a bad call — it's best for readers who want straightforward medication and supplies pricing and can resolve the membership and refund-cutoff questions before paying. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Rylo Health |
|---|---|---|
| Brief Score | 94/100 (A) | 71/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm the complete charge Advertises $139 monthly or $299 quarterly. Separate-service wording conflicts with the bundled no-membership offer. Full price detailsCompounded semaglutide offered; complete quote unknown because membership terms conflict; monthly offer $139 or $299 quarterly; earlier listing: From $149/mo (promotional rate, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm the complete charge Advertises $229 monthly or $479 quarterly. Separate-service wording conflicts with the bundled no-membership offer. Full price detailsCompounded tirzepatide offered; complete quote unknown because membership terms conflict; monthly offer $229 or $479 quarterly; earlier listing: From $249/mo (compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises access in all 50 states; confirm individual clinical and pharmacy eligibility |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Rylo Health: Public monthly options are $139 semaglutide/$229 tirzepatide; quarterly totals $299/$479. Membership wording prevents confirming the complete bill.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.